I don't disagree with your post, I am merely speak
Post# of 148172
What is fascinating about our drug is the safety profile that is well established, even more so impressive when you consider CCR5/CCL5 axis is "master regulator" so to speak. Disrupting an upstream receptor has profound effects, so far we have many positive effects and have yet to show negative effects.